loading

Akero Therapeutics Inc Azioni (AKRO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
0.45%
69.25
69.57 69.29 72.23 55.32
Interest Income/Expense
1.56%
1.172
1.154 1.20 1.246 1.231
Operating Income/Loss
0.01%
-80.87
-80.88 -78.03 -81.70 -65.74
Income/Loss From Continuing Operations Before Tax
0.31%
-70.50
-70.72 -70.02 -72.70 -55.99
Income/Loss From Continuing Operations After Tax
0.31%
-70.50
-70.72 -70.02 -72.70 -55.99
Net Income/Loss
0.31%
-70.50
-70.72 -70.02 -72.70 -55.99
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3.90%
81.72
78.66 1.154 69.44 69.16
Diluted Average Shares
3.90%
81.72
78.66 1.154 69.44 69.16
Basic Earnings Per Share
4.44%
-0.86
-0.90 -0.99 -1.05 -0.81
Diluted Earnings Per Share
4.44%
-0.86
-0.90 -0.99 -1.05 -0.81
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$83.69
price down icon 0.11%
$22.08
price up icon 2.69%
$32.13
price up icon 1.13%
$102.31
price up icon 0.35%
$164.72
price up icon 1.08%
biotechnology ONC
$328.88
price up icon 2.25%
Capitalizzazione:     |  Volume (24 ore):